Brolucizumab in Age-Related Macular Neovascularization (Brain Study): Efficacy, Optical Coherence Tomography Biomarkers and Safety Profile over 18 Months
Background: Brolucizumab is a new anti-Vascular Endothelial Growth Factor (anti-VEGF
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Background: Brolucizumab is a new anti-Vascular Endothelial Growth Factor (anti-VEGF
BACKGROUND This is a bilateral condition where there is a chronic granulomatous
BACKGROUND Vogt-Koyanagi-Harada syndrome is a granulomatous panuveitis with multisystemic manifestations
BACKGROUND Intermediate uveitis is a form of uveitis localised to the vitreous
BACKGROUND Takayasu arteritis is a chronic inflammatory vasculopathy mainly affecting the aorta
BACKGROUND The firm belief that only a severe blow to the eye
For authors and organisers
Find the right journal for your paper and submit your manuscript.